Clinical Trial Update: Efficacy of Synbiotic Supplementation on IL-10, TGF-B and Disease Activity in Systemic Lupus Erythematosus Patients [NA]

View source ↗

Summary

A completed clinical trial evaluated whether synbiotic supplementation affects IL-10, TGF-beta levels, and disease activity in systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Synbiotic supplementation

Snippet

Sponsor: Universitas Sriwijaya | Conditions: Systemic Lupus Erythematosus | NA | Status: COMPLETED